Eszopiclone

Product NDC: 53217-307
11-digit product format: 532170307
Labeler code: 53217
Product ID: 53217-307_4f0270d8-fdba-4379-893f-0dc9269273e4
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Eszopiclone
Dosage form: TABLET, COATED
Route: ORAL
Labeler: Aidarex Pharmaceuticals LLC
Application: ANDA091024
Marketing category: ANDA
Marketing start: 2014-04-15
Marketing end: 0000-00-00
Substance: ESZOPICLONE
Active strength: 2 mg/1
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	53217-307		I	Inactivated by FDA	2026-10-15
excluded package	package	53217-307	53217-307-30	I	Inactivated by FDA	2026-10-15
excluded package	package	53217-307	53217-307-60	I	Inactivated by FDA	2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 66 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53217-307-30	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53217-307-60	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53217-307-30	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53217-307-60	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53217-307-30	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53217-307-60	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53217-307-30	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53217-307-60	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53217-307-30	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53217-307-60	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53217-307-30	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53217-307-60	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53217-307-30	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53217-307-60	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53217-307-30	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53217-307-60	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53217-307-30	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53217-307-60	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	53217-307-30	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	53217-307-60	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	53217-307-30	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	53217-307-60	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	53217-307-30	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	53217-307-60	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	53217-307-30	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	53217-307-60	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	53217-307-30	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	53217-307-60	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	53217-307-30	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	53217-307-60	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	53217-307-30	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	53217-307-60	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	53217-307-30	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	53217-307-60	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	53217-307-30	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	53217-307-60	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	53217-307-30	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	53217-307-60	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53217-307-30	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53217-307-60	`e2bbac7714bc…`	`27bdfed8d636…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A091024-001	ESZOPICLONE	ESZOPICLONE	1MG	TABLET / ORAL	AB	2014-04-15
A091024-002	ESZOPICLONE	ESZOPICLONE	2MG	TABLET / ORAL	AB	2014-04-15
A091024-003	ESZOPICLONE	ESZOPICLONE	3MG	TABLET / ORAL	AB	2014-04-15

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A091024-001	AB
A091024-002	AB
A091024-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 132 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	A091024-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2014-04-15	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A091024-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2014-04-15	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A091024-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2014-04-15	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A091024-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2014-04-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A091024-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2014-04-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A091024-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2014-04-15	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A091024-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2014-04-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A091024-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2014-04-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A091024-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2014-04-15	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A091024-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2014-04-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091024-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2014-04-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091024-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2014-04-15	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091024-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2014-04-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091024-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2014-04-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091024-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2014-04-15	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A091024-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2014-04-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091024-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2014-04-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091024-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2014-04-15	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091024-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2014-04-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091024-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2014-04-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091024-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2014-04-15	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091024-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2014-04-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091024-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2014-04-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091024-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2014-04-15	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091024-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2014-04-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091024-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2014-04-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091024-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2014-04-15	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091024-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2014-04-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091024-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2014-04-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091024-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2014-04-15	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091024-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2014-04-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091024-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2014-04-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091024-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2014-04-15	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091024-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2014-04-15	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091024-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2014-04-15	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091024-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2014-04-15	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A091024-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2014-04-15	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A091024-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2014-04-15	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A091024-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2014-04-15	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A091024-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2014-04-15	`79d66fd596c7…`

Observed Orange Book normalized TE history#

Normalized TE history page 4 of 4 · 132 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-10-28 04:53 UTC	2022-10	A091024-001	AB	1	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	A091024-002	AB	1	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	A091024-003	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A091024-001	AB	1	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	A091024-002	AB	1	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	A091024-003	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A091024-001	AB	1	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A091024-002	AB	1	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A091024-003	AB	1	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A091024-001	AB	1	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A091024-002	AB	1	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A091024-003	AB	1	`a50c72e98297…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f65008ed-f925-2246-581a-e6a3201df7e4	Product name	5	20250107

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
53217-307-30	2020-01-31	C162847	48780-1	9d75b9d1-0f84-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use eszopiclone tablets safely and effectively. See full prescribing information for eszopiclone tablets. Eszopiclone Tablets, for oral use, CIV Initial U.S. Approval: 2004
53217-307-60	2020-01-31	C162847	48780-1	9d75b9d1-0f84-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use eszopiclone tablets safely and effectively. See full prescribing information for eszopiclone tablets. Eszopiclone Tablets, for oral use, CIV Initial U.S. Approval: 2004

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
53217-307-30	Eszopiclone	30 in 1 BOTTLE	TABLET, COATED	30		1
53217-307-60	Eszopiclone	60 in 1 BOTTLE	TABLET, COATED	60		1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
53217-307-30	EA - Each	53217-307	9ab466ad-1916-4e6b-bf96-3a8bd1206d58	1	2017-07-07
53217-307-60	EA - Each	53217-307	bd7c44b0-647b-4a71-8e12-1bb5da326b63	1	2017-07-07

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
53217-307	ESZOPICLONE TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1	Legacy NDC, 2 package rows	20170630_8edd5f22-cbdb-4286-8b35-9d09d84dafd7.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Eszopiclone	ESZOPICLONE	Advanced Rx of Tennessee, LLC	af86ebdb-e47b-706a-e053-2995a90ad51c	2024-12-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 091024 application number: ANDA091024
Eszopiclone	ESZOPICLONE	Advanced Rx of Tennessee, LLC	af86b753-d2ee-9b5f-e053-2a95a90ad23d	2024-12-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 091024 application number: ANDA091024
Eszopiclone	ESZOPICLONE	Dr. Reddy's Laboratories Limited	0b363b90-93dc-1fc1-0501-d140dfc762c7	2024-12-19	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 091024 application number: ANDA091024

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
UZX80K71OE	ESZOPICLONE	138729-47-2	ESZOPICLONE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
485442	eszopiclone 2 MG Oral Tablet	PSN	8edd5f22-cbdb-4286-8b35-9d09d84dafd7	1
485442	eszopiclone 2 MG Oral Tablet	SCD	8edd5f22-cbdb-4286-8b35-9d09d84dafd7	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
53217-307-30	53217030730	30 in 1 BOTTLE	Historical
53217-307-60	53217030760	60 in 1 BOTTLE	Historical